FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly hematology, cardiology and endocrinology, and thrombin time normalisation for metabolic syndrome (MS) patients. Method involves complex 3 month therapy consisting of individual hypocaloric diet, sensibly graded physical exercise, and administration of 30 mg of pioglitazone once per day and 80 mg of valsartan once at the same day time. This complex of non-drug treatment and specified medicines combined with course duration selected empirically ensures normalisation of thrombin generation rate and volume leading to thrombin time normalisation due to therapeutical effect potentiation for single complex therapy components for MS patients.
EFFECT: normalisation of thrombin generation rate and volume.
1 ex
